These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 14737967)

  • 21. Bacteriophages support anti-tumor response initiated by DC-based vaccine against murine transplantable colon carcinoma.
    Pajtasz-Piasecka E; Rossowska J; Duś D; Weber-Dabrowska B; Zabłocka A; Górski A
    Immunol Lett; 2008 Feb; 116(1):24-32. PubMed ID: 18166233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic cell-tumor fusion vaccines for renal cell carcinoma.
    Avigan D
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6347S-52S. PubMed ID: 15448029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunology in medical practice. XXV. Use of dendritic cells in the immunotherapy of cancer].
    Punt CJ; de Vries IJ; Mulders PF; Adema GJ; Figdor CG
    Ned Tijdschr Geneeskd; 1999 Nov; 143(48):2408-14. PubMed ID: 10608974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guiding the "misguided" - functional conditioning of dendritic cells for the DC-based immunotherapy against tumours.
    Huang FP; Chen YX; To CK
    Eur J Immunol; 2011 Jan; 41(1):18-25. PubMed ID: 21182072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene transfer approaches in cancer immunotherapy.
    Larin SS; Georgiev GP; Kiselev SL
    Gene Ther; 2004 Oct; 11 Suppl 1():S18-25. PubMed ID: 15454953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies.
    Klippstein R; Pozo D
    Nanomedicine; 2010 Aug; 6(4):523-9. PubMed ID: 20085824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergy between in situ cryoablation and TLR9 stimulation results in a highly effective in vivo dendritic cell vaccine.
    den Brok MH; Sutmuller RP; Nierkens S; Bennink EJ; Toonen LW; Figdor CG; Ruers TJ; Adema GJ
    Cancer Res; 2006 Jul; 66(14):7285-92. PubMed ID: 16849578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.
    Fujii S
    Trends Immunol; 2008 May; 29(5):242-9. PubMed ID: 18372215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human dendritic cells: natural adjuvants in antitumor immunotherapy.
    Di Nicola M; Anichini A; Mortarini R; Bregni M; Parmiani G; Gianni AM
    Cytokines Cell Mol Ther; 1998 Dec; 4(4):265-73. PubMed ID: 10068060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IFN-alpha in the generation of dendritic cells for cancer immunotherapy.
    Santini SM; Lapenta C; Santodonato L; D'Agostino G; Belardelli F; Ferrantini M
    Handb Exp Pharmacol; 2009; (188):295-317. PubMed ID: 19031032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of dendritic cells for peptide-based vaccination in cancer immunotherapy.
    Salem ML
    Methods Mol Biol; 2014; 1139():479-503. PubMed ID: 24619701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity.
    den Brok MH; Sutmuller RP; Nierkens S; Bennink EJ; Frielink C; Toonen LW; Boerman OC; Figdor CG; Ruers TJ; Adema GJ
    Br J Cancer; 2006 Oct; 95(7):896-905. PubMed ID: 16953240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer immunotherapy with mRNA-transfected dendritic cells.
    Gilboa E; Vieweg J
    Immunol Rev; 2004 Jun; 199():251-63. PubMed ID: 15233739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-host immune interactions and dendritic cell dysfunction.
    Yang L; Carbone DP
    Adv Cancer Res; 2004; 92():13-27. PubMed ID: 15530555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination strategies for enhancing the efficacy of immunotherapy in cancer patients.
    Moschella F; Proietti E; Capone I; Belardelli F
    Ann N Y Acad Sci; 2010 Apr; 1194():169-78. PubMed ID: 20536466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dendritic cells and their use in the therapy of neoplastic diseases].
    Pospísilová D; Zavacká A; Hrusák O; Sedivá A; Spísek R; Bartůnková J
    Cas Lek Cesk; 2000 Aug; 139(17):519-23. PubMed ID: 11109283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intramuscular immunization with plasmid coexpressing tumour antigen and Flt-3L results in potent tumour regression.
    Fong CL; Mok CL; Hui KM
    Gene Ther; 2006 Feb; 13(3):245-56. PubMed ID: 16163376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendritic cell-based cancer therapy.
    Conrad C; Nestle FO
    Curr Opin Mol Ther; 2003 Aug; 5(4):405-12. PubMed ID: 14513684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Harnessing dendritic cells in cancer.
    Apetoh L; Locher C; Ghiringhelli F; Kroemer G; Zitvogel L
    Semin Immunol; 2011 Feb; 23(1):42-9. PubMed ID: 21295491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer immunogene therapy.
    Yoshizawa H; Kagamu H; Gejyo F
    Arch Immunol Ther Exp (Warsz); 2001; 49(5):337-43. PubMed ID: 11798131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.